Neoantigen-Based Cancer Immunotherapy: One Step Closer to the Promise of Personalized Medicine WhitepapersPeter Bak, PhDJune 3, 2018ASCO, Cancer, Check Point Inhibitors, immuno-oncology, Neoantigens, Oncology
